How much does Adagrasib cost per month?
Adagrasib is a small molecule targeted inhibitor of KRAS G12C mutation. It is mainly used to treat patients with specific types of advanced non-small cell lung cancer. At present, adagrasib has not been officially launched in my country. Therefore, if domestic patients need to use it, they can only obtain the drug through overseas medical channels or international pharmacies. Although this cross-border purchasing method provides patients with treatment opportunities, it also brings certain challenges in terms of cost and ease of access.
In terms of price, the adagrasibu on the US market is the original version of the drug, and the price is very high. Taking conventional dosage as an example, the cost of the original drug in the United States is approximately hundreds of thousands of yuan per month, which is undoubtedly a huge financial burden for most patient families. The high price is mainly related to the R&D cost of the original drug, clinical trial investment and market pricing strategy, so the price drop is unlikely in the short term.
In contrast, the imitation version of Adagraxi cloth produced in some overseas regions, especially Laos, provides a more people-friendly choice. The price of the Lao version of generic drugs is about more than 3,000 yuan per box, and the ingredients of the drugs are basically the same as the original drugs, which can guarantee a certain therapeutic effect. This generic drug has become an important alternative for many patients under financial pressure, giving more patients the opportunity to receive KRAS G12C targeted therapy.
Overall, since adagrasibu has not yet been marketed in China, if patients choose the original drug, the monthly cost may be as high as hundreds of thousands of yuan; if they choose the Lao generic drug, the monthly cost is greatly reduced to about a few thousand yuan. Different choices correspond to different economic pressures and access channels. Before deciding to take medication, patients are advised to fully understand the source, quality assurance, and formal purchasing channels of the medication to ensure that the treatment is safe and effective.
References:https://www.krazati.com/
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)